Clinical Trial Update: Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years [Phase 3]

View source ↗

Summary

Phase 3 trial comparing an adjuvanted Hepatitis B vaccine to a double dose of Engerix-B in adults on pre-dialysis or haemodialysis, aged 15 and older.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adjuvanted Hepatitis B vaccine (trial product) (Hepatitis B vaccine, adjuvanted)
• Engerix-B (hepatitis B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED